Active Not Recruiting OBSERVATIONAL NCT07170761

Biomarkers and Event Patterns of Vascular Disease in Hemodialysis (HEMOcalc)

Cross-sectional Biomarker Study for Vascular Calcification in Hemodialysis Patients

Sponsor: Elisabethinen Hospital

Conditions CKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder Vascular Disease

Updated 2 times since 2025 Last updated: Mar 3, 2026 Started: Oct 15, 2022 Primary completion: Dec 31, 2027 Completion: Dec 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07170761, this observational or N/A phase trial focuses on CKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder and Vascular Disease and remains ongoing. Sponsored by Elisabethinen Hospital, it has been updated 2 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

2 versions recorded

Mar 2026 — Present [monthly]

Active Not Recruiting
Oct 2025 — Mar 2026 [monthly]

Active Not Recruiting

First recorded

Oct 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Elisabethinen Hospital
Landeskrankenhaus Feldkirch
Medical University of Graz

Data source: Medical University of Graz

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Graz, Austria